World's Best Scientists 2026 revealed!
Jonathan P. Piccini

Jonathan P. Piccini

D-Index & Metrics

Medicine

D-Index
107
Citations
63699
World Ranking
6114
National Ranking
3272

Jonathan P. Piccini publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jonathan P. Piccini sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 833 publications — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jonathan P. Piccini D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jonathan P. Piccini sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 107 D-Index — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jonathan P. Piccini is affiliated with Duke University in the United States. Their research primarily spans the field of Medicine, with a strong focus on Cardiology and Cardiovascular Medicine.

The scientist's work covers several subfields and topics, including:

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Epidemiology
  • Economics and Econometrics
  • Internal Medicine

  • Atrial Fibrillation Management and Outcomes
  • Cardiac Arrhythmias and Treatments
  • Cardiac pacing and defibrillation studies
  • Cardiac electrophysiology and arrhythmias
  • Acute Ischemic Stroke Management
  • Health Systems, Economic Evaluations, Quality of Life
  • Cardiovascular Function and Risk Factors

Among recent publications featuring Jonathan P. Piccini's research contributions are:

  • 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS), 2020, European Heart Journal
  • 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, 2023, Circulation
  • 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation, 2023, Journal of the American College of Cardiology
  • Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure, 2021, Circulation
  • 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation, 2024, EP Europace

Jonathan P. Piccini has frequently published in venues including:

  • Heart Rhythm
  • Circulation
  • Journal of the American College of Cardiology
  • Journal of Cardiovascular Electrophysiology
  • Heart Rhythm O2

Frequent collaborators in their work include:

  • Sean D. Pokorney
  • Benjamin A. Steinberg
  • Mikhael F. El-Chami
  • Gregg C. Fonarow
  • Daniel J. Friedman

Best Publications

  • Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

    Manesh R. Patel;Kenneth W. Mahaffey;Jyotsna Garg;Guohua Pan

  • Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial

    Douglas L. Packer;Daniel B. Mark;Richard A. Robb;Kristi H. Monahan

  • Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment

    Keith A. A. Fox;Jonathan P. Piccini;Daniel Wojdyla;Richard C. Becker

  • Response to Letter Regarding Article, “Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation: Validation of the R2CHADS2 Index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study Cohorts”

    Jonathan P. Piccini;Susanna R. Stevens;YuChiao Chang;Daniel E. Singer

  • Arrhythmogenic Right Ventricular Dysplasia A United States Experience

    Darshan Dalal;Khurram Nasir;Chandra Bomma;Kalpana Prakasa

  • Incidence and Prevalence of Atrial Fibrillation and Associated Mortality Among Medicare Beneficiaries: 1993–2007

    Jonathan P. Piccini;Bradley G. Hammill;Moritz F. Sinner;Paul N. Jensen

  • Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration

    Ben Freedman;John Camm;Hugh Calkins;Jeffrey S Healey

  • Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.

    Daniel B. Mark;Kevin J. Anstrom;Shubin Sheng;Jonathan P. Piccini

  • Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)

    Jonathan L. Halperin;Graeme J. Hankey;Daniel M. Wojdyla;Jonathan P. Piccini

  • Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II Registry.

    Benjamin A. Steinberg;Benjamin A. Steinberg;Benjamin A. Steinberg;Peter Shrader;Laine Thomas;Jack Ansell

  • The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation

    Emily C. O'Brien;Da Juanicia N. Simon;Laine E. Thomas;Elaine M. Hylek

  • Atrial fibrillation in heart failure: what should we do?

    Dipak Kotecha;Jonathan P. Piccini

  • Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials

    Jonathan P. Piccini;Renato D. Lopes;Melissa H. Kong;Vic Hasselblad

  • Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial

    Benjamin A. Steinberg;Anne S. Hellkamp;Yuliya Lokhnygina;Manesh R. Patel

  • Outcomes After Cardioversion and Atrial Fibrillation Ablation in Patients Treated With Rivaroxaban and Warfarin in the ROCKET AF Trial

    Jonathan P. Piccini;Susanna R. Stevens;Yuliya Lokhnygina;Manesh R. Patel

  • Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure: Results From the CABANA Trial.

    Douglas L. Packer;Jonathan P. Piccini;Kristi H. Monahan;Hussein R. Al-Khalidi

  • Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary.

    Hein Heidbuchel;Peter Verhamme;Marco Alings;Matthias Antz

  • Outcomes of Temporary Interruption of Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation Results From the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)

    Matthew W. Sherwood;James D. Douketis;Manesh R. Patel;Jonathan P. Piccini

  • Clinical Features of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Associated With Mutations in Plakophilin-2

    Darshan Dalal;Lorraine H. Molin;Jonathan Piccini;Crystal Tichnell

  • Atrial Fibrillation and Diabetes Mellitus: JACC Review Topic of the Week

    Allen Wang;Jennifer B. Green;Jonathan L. Halperin;Jonathan P. Piccini

Frequent Co-Authors

Kenneth W. Mahaffey
Kenneth W. Mahaffey Stanford University
Gregg C. Fonarow
Gregg C. Fonarow University of California, Los Angeles
Daniel E. Singer
Daniel E. Singer Harvard University
Eric D. Peterson
Eric D. Peterson The University of Texas Southwestern Medical Center
Bernard J. Gersh
Bernard J. Gersh Mayo Clinic
Manesh R. Patel
Manesh R. Patel Duke University
Keith A.A. Fox
Keith A.A. Fox University of Edinburgh
Elaine M. Hylek
Elaine M. Hylek Boston University
Richard C. Becker
Richard C. Becker University of Cincinnati
Graeme J. Hankey
Graeme J. Hankey University of Western Australia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways in the medical field is an excellent way to advance your career and adapt to today's evolving healthcare landscape. For those aiming for the highest levels in nursing with less focus on research, you might consider dnp programs without dissertation, which can make achieving a terminal nursing degree more attainable.

If you want to begin your healthcare career quickly, fast track lpn programs allow you to enter the workforce in significantly less time than traditional routes.

For registered nurses looking to specialize in mental health, enrolling in the fastest psychiatric nurse practitioner program can open doors to specialized clinical roles while minimizing time spent in school.

Those interested in the administrative side of healthcare can strengthen their business skills with a health administration degree online, offering flexibility and affordability.

Each of these online degree options caters to different interests and career goals. Whether you're just starting out or looking to advance, the right program can help you shape a meaningful, successful future in medicine or healthcare.

Best Scientists Citing Jonathan P. Piccini

Trending Scientists

Recently Published Articles